Edition:
United States

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

6.90USD
20 Jul 2018
Change (% chg)

$-0.15 (-2.13%)
Prev Close
$7.05
Open
$7.05
Day's High
$7.07
Day's Low
$6.85
Volume
70,863
Avg. Vol
123,978
52-wk High
$14.00
52-wk Low
$5.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.32 December 21 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.86 1.86 1.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 4.59 6.70 3.60 3.75
Quarter Ending Dec-18 6 5.51 9.07 3.60 3.75
Year Ending Dec-18 6 21.04 26.81 17.50 30.34
Year Ending Dec-19 6 47.86 152.00 5.23 65.45
Earnings (per share)
Quarter Ending Sep-18 6 -0.32 -0.27 -0.38 -0.47
Quarter Ending Dec-18 6 -0.33 -0.27 -0.42 -0.47
Year Ending Dec-18 6 -1.24 -1.09 -1.43 -1.50
Year Ending Dec-19 6 -1.07 0.04 -1.51 -1.19

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 4.37 6.63 2.26 51.73
Quarter Ending Dec-17 4.21 3.76 0.46 10.82
Quarter Ending Sep-17 6.13 3.79 2.34 38.14
Quarter Ending Jun-17 11.19 5.92 5.28 47.14
Quarter Ending Mar-17 4.53 3.77 0.76 16.77

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4.59 4.59 4.82 4.82 3.75
Quarter Ending Dec-18 5.51 5.51 5.88 5.88 3.75
Year Ending Dec-18 21.04 21.04 21.91 21.91 30.34
Year Ending Dec-19 47.86 47.53 27.23 40.10 65.45

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 1 0 1
Quarter Ending Dec-18 0 1 0 1
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 1 0 1 0
Earnings